Article
Sun Pharmaceutical Industries, based in India, will acquire DUSA Pharmaceuticals, aiming to advance into the dermatologic market in the United States.
Information on TikTok About Spironolactone is Unreliable, New Study Finds
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Developing Personalized Approaches for Atopic Dermatitis Treatment
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Beyond the Surface: How Skin Conditions Affect Daily Life
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD